Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alexander Tells FDA To Create ‘Red Team’ For Regulatory Streamlining

This article was originally published in The Tan Sheet

Executive Summary

HELP Committee Chairman Lamar Alexander wants FDA to suggest regs and other bureaucratic requirements that are hindering productivity as part of medical innovation effort.

You may also be interested in...



FDA Simplifies The Process For REMS Changes

Some typographical changes can be submitted and noted later, according to new draft guidance. Major changes still require pre-approval.

FDA’s Top Two Reform Priorities Aren’t Really Legislative Material

Senate eyes a biomedical reform process that is simultaneously narrower and slower than the House’s 21st Century Cures Initiative; FDA’s Hamburg asks for ability to shape sponsor’s trial designs earlier and more regulatory science funding.

‘Precision Medicine’ Gets R&D Funding Push In President’s Speech

President Obama highlights potential for personalized medicine in his State of the Union address and will seek a “major increase” in research and development funding.

Related Content

Topics

UsernamePublicRestriction

Register

PS107640

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel